GTMRx Shares New Report on Value of Implementing and Integrating Comprehensive Medication Management in Team-Based Care

Share Article

Organization of Key Health Care Stakeholders Releases Third Annual Evidence Document, 11th Guidance Document for 2022

News Image
“Payors and physicians are asking for evidence on the value and investing in CMM as they seek to offer value-driving services in primary care,” said Katherine H. Capps, co-founder and executive director at GTMRx.

Today, The Get the Medications Right™ (GTMRx) Institute, a coalition of over 1,700 members calling for medication management reform bringing together critical stakeholders across health care, is sharing its quick reference evidence document outlining the outcomes of implementing and integrating comprehensive medication management (CMM) in team-based care, including a review of the evidence of quality, access and costs. CMM is a patient-centered approach to optimizing medication use and improving patient health outcomes.

“With the third release of the GTMRx evidence document, we are encouraged to see quality literature being published surrounding CMM and the ability to improve care surrounding the quadruple aim,” said M. Shawn McFarland, PharmD, FCCP, BCACP, National Clinical Pharmacy Practice Program Manager Clinical Pharmacy Practice Office, Pharmacy Benefits Management Services, Veterans Health Administration. “This annual evidence document should strengthen the use case for CMM and continue to be a shining light of what our health care system can become.”

Each year in the United States, more than $528 billion is spent, and 275,000 lives are lost due to non-optimized medication use. Over 80% of Americans are taking one or more medications per week, and rates of hospital admissions resulting from medication-related problems continue to be on the rise — as a result, GTMRx is committed to providing awareness and a strategy to ensure that the industry works to “get the medications right” for all patients.

“Payors and physicians are asking for evidence on the value and investing in CMM as they seek to offer value-driving services in primary care,” said Katherine H. Capps, co-founder and executive director at GTMRx. “Using CMM is part of a “whole health” approach and is a missing ingredient essential to achieve medication optimization. Medication misuse, overuse, and underuse must be addressed as we seek to deliver accountable, affordable, and appropriate care.”

Key findings from the document highlight that regardless of the location, when CMM is integrated into team-based care, therapeutic goals are achieved, costs decrease, and the patient and provider experience improves. The CMM patient care process ensures each patient’s medications (whether prescription, nonprescription, alternative, traditional, vitamins, or nutritional supplements) are individually assessed to determine that each medication has an appropriate indication, is effective for the medical condition and achieves defined patient and clinical goals, is safe given the comorbidities and other medications being taken and that the patient can take the medication as intended and adhere to the prescribed regimen.

“The report showcases results from multiple settings and showcases one of the largest studies of patient experience (satisfaction) seeing a clinical pharmacist for CMM services at a Veterans Health Administration (VHA) facility, along with the impact of a pharmacogenomics-enriched CMM program in reducing health care costs,” said Marcia Buck, Pharm.D., FCCP, BCPPS and the director of clinical practice advancement for the American College of Clinical Pharmacy (ACCP). “It is our hope that by presenting the best of the published data from rigorous studies with increasingly larger patient samples, we will continue to drive the implementation of CMM in more practice sites until it becomes a routine component of team-based patient care.”

“We have long known that CMM can improve quality of care, reduce costs and improve the patient and provider experience,” added Capps. “Now we have evidence to show that when a clinical pharmacist, working in collaborative practice with a physician, uses CMM to identify, address, and mitigate the effects of adverse social determinants of health, they play a role in achieving the fifth component of the new quintuple aim of health care: health equity.”

To read the report, click here. And for more about the value of CMM, check out our explainer video.

About the Get the Medications Right™ Institute
The GTMRx Institute is a catalyst for change that brings critical stakeholders together, bound by the urgent need to get the medications right. We are physicians, pharmacists, nurses, patients, health IT innovators, drug and diagnostics companies, consumer groups, employers, and payers — aligned to save lives and save money through comprehensive medication management. We motivate practice transformation and push payment and policy reform by showcasing evidence and innovation. Together, we ACT to champion the appropriate, effective, safe, and precise use of medication and gene therapies. Learn more at gtmr.org. See the recently published GTMRx article in Health Affairs Forefront. Comprehensive Medication Management: A Missing Ingredient In Value-Based Payment Models | Health Affairs

###

Media Contact:
Aimee Eichelberger
Aimee (at) superior (dot) com
312.952.1528

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eichelberger
Visit website